High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 11, 2010, Pages 5097-5104

  Zhu, Na ^a   Pankow, James S ^a   Ballantyne, Christie M ^b   Couper, David ^c   Hoogeveen, Ron C ^b   Pereira, Mark ^a   Duncan, Bruce B ^c,d   Schmidt, Maria Inês ^c,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c IL   (United States)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; INSULIN; INTERLEUKIN 6; OROSOMUCOID; SIALIC ACID;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BODY MASS; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOLECULAR WEIGHT; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; WAIST HIP RATIO;

EID: 78049500911     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0716     Document Type: Article

References (31)

1. Yamauchi T, Kadowaki T 2008 Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes (Lond) 32(Suppl 7):S13-S18
2. Sowers JR 2008 Endocrine functions of adipose tissue: focus on adiponectin. Clin Cornerstone 9:32-40
3. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749
4. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G 2004 Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 53:2473-2478 (Pubitemid 39145606)
5. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Löwel H 2006 Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol 48:1369-1377 (Pubitemid 44436825)
6. Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM 2006 Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn study. Diabetes Care 29:2498-2503
7. Wannamethee SG, Lowe GD, Rumley A, Cherry L, Whincup PH, Sattar N 2007 Adipokines and risk of type 2 diabetes in older men. Diabetes Care 30:1200-1205
8. Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, Mantzoros CS, Hu FB 2008 Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 149:307-316
9. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T; Funagata Study 2003 Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 26:2015-2020
10. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH 2004 Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol (Oxf) 61:75-80
11. Dibello JR, Baylin A, Viali S, Tuitele J, Bausserman L, McGarvey ST 2009 Adiponectin and type 2 diabetes in Samoan adults. Am J Hum Biol 21:389-391
12. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J 2002 Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360:57-58
13. Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A 2003 Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians. Diabetes Care 26:3226-3229
14. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE 2003 Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278:9073-9085
15. Peake PW, Kriketos AD, Campbell LV, Shen Y, Charlesworth JA 2005 The metabolism of isoforms of human adiponectin: studies in human subjects and in experimental animals. Eur J Endocrinol 153:409-417
16. Oh DK, Ciaraldi T, Henry RR 2007 Adiponectin in health and disease. Diabetes Obes Metab 9:282-289
17. Wang Y, Lam KS, Yau MH, Xu A 2008 Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 409:623-633
18. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N 2006 Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 91:3873-3877
19. Basu R, Pajvani UB, Rizza RA, Scherer PE 2007 Selective down-regulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 56:2174-2177 (Pubitemid 47195840)
20. Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G; the ARIC Investigators 2006 Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49:2086-2096
21. Jehn ML, Guallar E, Clark JM, Couper D, Duncan BB, Ballantyne CM, Hoogeveen RC, Harris ZL, Pankow JS 2007 A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 165:1047-1054
22. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study 2003 Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52:1799-1805
23. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G 1999 Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet 353:1649-1652
24. Ebinuma H, Miyazaki O, Yago H, Hara K, Yamauchi T, Kadowaki T 2006 A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin Chim Acta 372:47-53
25. Kaser S, Tatarczyk T, Stadlmayr A, Ciardi C, Ress C, Tschoner A, Sandhofer A, Paulweber B, Ebenbichler CF, Patsch JR 2008 Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Invest 38:827-834
26. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y 2004 Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94:e27-e31
27. Seino Y, Hirose H, Saito I, Itoh H 2009 High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men. Metabolism 58:355-360
28. Fisher FF, Trujillo ME, Hanif W, Barnett AH, McTernan PG, Scherer PE, Kumar S 2005 Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 48:1084-1087
29. Lara-Castro C, Doud EC, Tapia PC, Munoz AJ, Fernandez JR, Hunter GR, Gower BA, Garvey WT 2008 Adiponectin multimers and metabolic syndrome traits: relative adiponectin resistance in African Americans. Obesity (Silver Spring) 16:2616-2623
30. Berg AH, Combs TP, Scherer PE 2002 ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89
31. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946